Stark Christina, Münßinger Sini, Rosenau Frank, Eikmanns Bernhard J, Schwentner Andreas
Institute of Microbiology and Biotechnology, University of Ulm, Ulm, Germany.
Institute of Pharmaceutical Biotechnology, University of Ulm, Ulm, Germany.
Front Microbiol. 2022 Jun 3;13:907577. doi: 10.3389/fmicb.2022.907577. eCollection 2022.
Today production of (bulk) chemicals and fuels almost exclusively relies on petroleum-based sources, which are connected to greenhouse gas release, fueling climate change. This increases the urgence to develop alternative bio-based technologies and processes. Gaseous and liquid C1 compounds are available at low cost and often occur as waste streams. Acetogenic bacteria can directly use C1 compounds like CO, CO, formate or methanol anaerobically, converting them into acetate and ethanol for higher-value biotechnological products. However, these microorganisms possess strict energetic limitations, which in turn pose limitations to their potential for biotechnological applications. Moreover, efficient genetic tools for strain improvement are often missing. However, focusing on the metabolic abilities acetogens provide, they can prodigiously ease these technological disadvantages. Producing acetate and ethanol from C1 compounds can fuel bio-based intermediates conversion into more energy-demanding, higher-value products, by deploying aerobic organisms that are able to grow with acetate/ethanol as carbon and energy source. Promising new approaches have become available combining these two fermentation steps in sequential approaches, either as separate fermentations or as integrated two-stage fermentation processes. This review aims at introducing, comparing, and evaluating the published approaches of sequential C1 fermentations, delivering a list of promising organisms for the individual fermentation steps and giving an overview of the existing broad spectrum of products based on acetate and ethanol. Understanding of these pioneering approaches allows collecting ideas for new products and may open avenues toward making full use of the technological potential of these concepts for establishment of a sustainable biotechnology.
如今,(大宗)化学品和燃料的生产几乎完全依赖于石油基来源,这与温室气体排放相关,加剧了气候变化。这增加了开发替代性生物基技术和工艺的紧迫性。气态和液态C1化合物成本低廉,且常作为废物流出现。产乙酸细菌可以厌氧方式直接利用一氧化碳、二氧化碳、甲酸或甲醇等C1化合物,将它们转化为乙酸和乙醇,用于生产更高价值的生物技术产品。然而,这些微生物存在严格的能量限制,这反过来又限制了它们在生物技术应用中的潜力。此外,通常缺少用于菌株改良的高效遗传工具。然而,鉴于产乙酸菌所具备的代谢能力,它们能够极大地缓解这些技术劣势。通过利用能够以乙酸/乙醇作为碳源和能源生长的需氧生物,从C1化合物生产乙酸和乙醇可为生物基中间体转化为更耗能、更高价值的产品提供助力。将这两个发酵步骤以连续方式结合起来,无论是作为单独发酵还是作为集成式两阶段发酵过程,都已出现了一些有前景的新方法。本综述旨在介绍、比较和评估已发表的连续C1发酵方法,列出各个发酵步骤中有前景的微生物,并概述基于乙酸和乙醇的现有广泛产品种类。对这些开创性方法的理解有助于为新产品收集思路,并可能为充分利用这些概念的技术潜力以建立可持续生物技术开辟道路。